# Gadodiamide + Caldiamide

## OmniSCAN inj 0.5 mmol/mL， 20mL

##### 

| TAH Drug Code      | IOMNI                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | 腦脊髓磁振顯影及全身磁振顯影 Magnetic resonance imaging, Brain, spine and associated tissues; Intrathoracic (noncardiac), abdominal, pelvic, and retroperitoneal regions.                                                                                                                                                                                  |
| Dosing             | Magnetic resonance imaging, Brain, spine and associated tissues; Intrathoracic (noncardiac), abdominal, pelvic, and retroperitoneal regions: CNS imaging, 0.2 mL/kg (0.1 mmol/kg) as an IV bolus injection. kidney imaging, 0.1 mL/kg (0.05 mmol/kg) IV. intrathoracic (noncardiac), intra-abdominal, pelvic cavities imaging, 0.2 mL/kg (0.1 mmol/kg) IV. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Kidney disease, chronic and severe (GFR less than 30 mL/min/1.73 m(2)); high risk for fatal or debilitating nephrogenic systemic fibrosis. Kidney injury, acute; high risk for fatal or debilitating nephrogenic systemic fibrosis. Hypersensitivity to gadodiamide or any component of the formulation.                                                   |
| Adverse Effects    | 溫、涼感所造成的不適, 注射部位疼痛(常見), 暈眩, 噁心, 頭痛, 味覺及嗅覺改變, 嘔吐, 嗜睡, 感覺異常, 視覺模糊, 下痢, 焦躁不安, 呼吸困難, 胸痛, 心動過速, 顫抖, 關節疼痛 Dermatologic: Nephrogenic systemic fibrosis. Renal: Injury of kidney, Acute.                                                                                                          |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | Human Data Suggest Potential Toxicity                                                                                                                                                                                                                                                                                                                      |

